Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07344714 · ClinicalTrials.gov registry record
Predicting the Need for Prolonged Respiratory Support in Neonates Delivered in a Lower-Level NICU Setting
A clinical trial of Respiratory Distress Syndrome, Newborn and Pneumothorax, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT07344714: Recruiting study of Respiratory Distress Syndrome, Newborn and Pneumothorax, sponsored by Mayo Clinic.
NCT07344714 is a study of Respiratory Distress Syndrome, Newborn and Pneumothorax that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 500 participants, above the 145-participant average among 8 other Respiratory Distress Syndrome, Newborn trials with a reported enrollment target (245% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07344714, a study of Respiratory Distress Syndrome, Newborn and Pneumothorax, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to analyze the gastric fluid aspirated from the stomachs of neonates receiving routine post-delivery care to predict the need for prolonged respiratory support (\>6 hours of life).
Primary Outcome
Calculated sensitivity, specificity, positive- and negative-predictive values of the predicted outcomes compared to actual patient outcomes.
Conditions Studied
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2026-03-11 |
| Est. Completion | 2026-12-31 |
What NCT07344714 shows while recruiting
NCT07344714 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 145-participant average among 8 other Respiratory Distress Syndrome, Newborn trials with a reported enrollment target (245% higher).
The record links to 8 conditions, with Respiratory Distress Syndrome, Newborn appearing as the primary indexed condition, and to 0 interventions.
NCT07344714 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT07344714 about?
NCT07344714 is a clinical study titled "Predicting the Need for Prolonged Respiratory Support in Neonates Delivered in a Lower-Level NICU Setting". The purpose of this study is to analyze the gastric fluid aspirated from the stomachs of neonates receiving routine post-delivery care to predict the need for prolonged respiratory support (\>6 hours of life).
What is the current status of trial NCT07344714?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2026-03-11. Estimated completion is 2026-12-31.
What conditions does trial NCT07344714 study?
This clinical trial studies the following conditions: Respiratory Distress Syndrome, Newborn, Pneumothorax, Transient Tachypnea of the Newborn, Respiratory Distress Syndrome in Premature Infant, Meconium Aspiration Syndrome.
Who is sponsoring clinical trial NCT07344714?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07344714 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Respiratory Distress Syndrome, Newborn
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07344714's enrollment target sits among peer trials
500 2nd of 8 the highest of 8 other Respiratory Distress Syndrome, Newborn trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Respiratory Distress Syndrome, Newborn trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Echography-guided Surfactant THERapy (ESTHER) For Preterm Infants With Respiratory Failure
RECRUITING · NA
-
Prophylactic Minimally Invasive Surfactant Evaluation
RECRUITING · Phase 4
-
Pulmonary Function Using Non-invasive Forced Oscillometry
ACTIVE NOT RECRUITING · NA
-
ETCare: Safety and Preliminary Efficacy Trial
COMPLETED · Early Phase 1
-
Aerosolized Surfactant in Neonatal RDS
COMPLETED · Phase 1
-
Work of Breathing During Non-invasive Ventilation in Premature Neonates
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI